27763528|t|Up-Regulation of Claudin-6 in the Distal Lung Impacts Secondhand Smoke -Induced Inflammation
27763528|a|It has long been understood that increased epithelial permeability contributes to inflammation observed in many respiratory diseases. Recently, evidence has revealed that environmental exposure to noxious material such as cigarette smoke reduces tight junction barrier integrity, thus enhancing inflammatory conditions. Claudin-6 (Cldn6) is a tetraspanin transmembrane protein found within the tight junctional complex and is implicated in maintaining lung epithelial barriers. To test the hypothesis that increased Cldn6 ameliorates inflammation at the respiratory barrier, we utilized the Tet-On inducible transgenic system to conditionally over-express Clnd6 in the distal lung. Cldn6 transgenic (TG) and control mice were continuously provided doxycycline from postnatal day (PN) 30 until euthanasia date at PN90. A subset of Cldn6 TG and control mice were also subjected to daily secondhand tobacco smoke (SHS) via a nose only inhalation system from PN30-90 and compared to room air (RA) controls. Animals were euthanized on PN90 and lungs were harvested for histological and molecular characterization. Bronchoalveolar lavage fluid (BALF) was procured for the assessment of inflammatory cells and molecules. Quantitative RT-PCR and immunoblotting revealed increased Cldn6 expression in TG vs. control animals and SHS decreased Cldn6 expression regardless of genetic up-regulation. Histological evaluations revealed no adverse pulmonary remodeling via Hematoxylin and Eosin (H&amp;E) staining or any qualitative alterations in the abundance of type II pneumocytes or proximal non-ciliated epithelial cells via staining for cell specific propeptide of Surfactant Protein-C (proSP-C) or Club Cell Secretory Protein (CCSP), respectively. Immunoblotting and qRT-PCR confirmed the differential expression of Cldn6 and the pro-inflammatory cytokines TNF-α and IL-1β. As a general theme, inflammation induced by SHS exposure was influenced by the availability of Cldn6. These data reveal captivating information suggesting a role for Cldn6 in lungs exposed to tobacco smoke. Further research is critically necessary in order to fully explain roles for tight junctional components such as Cldn6 and other related molecules in lungs coping with exposure.
27763528	0	13	Up-Regulation	T044	C0041904
27763528	17	26	Claudin-6	T116	C0909824
27763528	34	40	Distal	T082	C0205108
27763528	41	45	Lung	T023	C0024109
27763528	54	70	Secondhand Smoke	T037	C0375734
27763528	80	92	Inflammation	T046	C0021368
27763528	136	146	epithelial	T080	C0221908
27763528	147	159	permeability	T070	C0031164
27763528	175	187	inflammation	T046	C0021368
27763528	205	225	respiratory diseases	T047	C0035204
27763528	264	286	environmental exposure	T037	C0014412
27763528	290	306	noxious material	T131	C1254354
27763528	315	330	cigarette smoke	T131	C0239059
27763528	339	353	tight junction	T030	C0242358
27763528	354	361	barrier	T024	C0225694
27763528	362	371	integrity	T080	C1947912
27763528	388	411	inflammatory conditions	UnknownType	C0544805
27763528	413	422	Claudin-6	T116	C0909824
27763528	424	429	Cldn6	T116	C0909824
27763528	436	469	tetraspanin transmembrane protein	T116	C0021699
27763528	487	511	tight junctional complex	T030	C0229984
27763528	545	569	lung epithelial barriers	T024	C0225694
27763528	609	614	Cldn6	T116	C0909824
27763528	627	639	inflammation	T046	C0021368
27763528	647	666	respiratory barrier	T024	C0225694
27763528	701	718	transgenic system	T028	C0282641
27763528	736	748	over-express	T045	C1514559
27763528	749	754	Clnd6	T116,T123	C1570898
27763528	762	768	distal	T082	C0205108
27763528	769	773	lung	T023	C0024109
27763528	775	791	Cldn6 transgenic	T015	C0025936
27763528	793	795	TG	T015	C0025936
27763528	801	808	control	T008	C1511501
27763528	809	813	mice	T015	C0025929
27763528	841	852	doxycycline	T109,T195	C0013090
27763528	858	871	postnatal day	T079	C1254367
27763528	873	875	PN	T079	C1254367
27763528	886	896	euthanasia	T058	C1136183
27763528	905	909	PN90	T079	C1254367
27763528	923	931	Cldn6 TG	T015	C0025936
27763528	936	943	control	T008	C1511501
27763528	944	948	mice	T015	C0025929
27763528	972	977	daily	T079	C0332173
27763528	978	1002	secondhand tobacco smoke	T037	C0375734
27763528	1004	1007	SHS	T037	C0375734
27763528	1015	1019	nose	T023	C0028429
27763528	1025	1042	inhalation system	T022	C0460002
27763528	1048	1055	PN30-90	T079	C1254367
27763528	1072	1080	room air	T033	C3846005
27763528	1082	1084	RA	T033	C3846005
27763528	1096	1103	Animals	T008	C0003062
27763528	1109	1119	euthanized	T058	C1136183
27763528	1123	1127	PN90	T079	C1254367
27763528	1132	1137	lungs	T023	C0024109
27763528	1157	1169	histological	T169	C0205462
27763528	1174	1200	molecular characterization	T052	C1880022
27763528	1202	1230	Bronchoalveolar lavage fluid	T031	C0006279
27763528	1232	1236	BALF	T031	C0006279
27763528	1259	1269	assessment	T058	C0220825
27763528	1273	1291	inflammatory cells	T025	C0440752
27763528	1296	1305	molecules	T167	C0567416
27763528	1307	1326	Quantitative RT-PCR	T063	C0599161
27763528	1331	1345	immunoblotting	T059	C0020985
27763528	1365	1370	Cldn6	T116,T123	C1570898
27763528	1371	1381	expression	T045	C1171362
27763528	1385	1387	TG	T015	C0025936
27763528	1392	1407	control animals	T008	C1511501
27763528	1412	1415	SHS	T037	C0375734
27763528	1426	1431	Cldn6	T116,T123	C1570898
27763528	1432	1442	expression	T045	C1171362
27763528	1465	1478	up-regulation	T044	C0041904
27763528	1480	1492	Histological	T169	C0205462
27763528	1493	1504	evaluations	T058	C0220825
27763528	1525	1534	pulmonary	T023	C0024109
27763528	1550	1590	Hematoxylin and Eosin (H&amp;E) staining	T059	C0523207
27763528	1629	1638	abundance	T080	C2346714
27763528	1642	1661	type II pneumocytes	T025	C0225700
27763528	1665	1703	proximal non-ciliated epithelial cells	T025	C0014597
27763528	1708	1716	staining	T059	C0487602
27763528	1721	1725	cell	T025	C0007634
27763528	1735	1769	propeptide of Surfactant Protein-C	T116,T123	C1454562
27763528	1771	1778	proSP-C	T116,T123	C1454562
27763528	1783	1810	Club Cell Secretory Protein	T116,T121	C1505368
27763528	1812	1816	CCSP	T116,T121	C1505368
27763528	1833	1847	Immunoblotting	T059	C0020985
27763528	1852	1859	qRT-PCR	T063	C1514628
27763528	1887	1897	expression	T045	C1171362
27763528	1901	1906	Cldn6	T116,T123	C1570898
27763528	1915	1941	pro-inflammatory cytokines	T129	C0021054
27763528	1942	1947	TNF-α	T116,T129	C0041368
27763528	1952	1957	IL-1β	T116,T129	C0021753
27763528	1979	1991	inflammation	T046	C0021368
27763528	2003	2006	SHS	T037	C0375734
27763528	2007	2015	exposure	T033	C0243095
27763528	2054	2059	Cldn6	T116,T123	C1570898
27763528	2125	2130	Cldn6	T116,T123	C1570898
27763528	2134	2139	lungs	T023	C0024109
27763528	2140	2147	exposed	T033	C0243095
27763528	2151	2164	tobacco smoke	T131	C0439994
27763528	2243	2270	tight junctional components	T030	C0229984
27763528	2279	2284	Cldn6	T116	C0909824
27763528	2303	2312	molecules	T167	C0567416
27763528	2316	2321	lungs	T023	C0024109
27763528	2334	2342	exposure	T033	C0243095